Fit Body ScienceEvidence-based fitness analysis
0Studies tracked
0Claims cite
0Videos use
Average study score: 52/100

Bibliography

Studies by this author

1 study attributed to Yujiro Nakano on the platform. Click a card to read the full analysis.

Study

Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study

This study investigates whether ipragliflozin, an SGLT2 inhibitor, reduces epicardial fat volume (EFV) in non-obese adults with type 2 diabetes and visceral adiposity.

Read analysis
Yujiro Nakano — Research Author · Fit Body Science